159 related articles for article (PubMed ID: 34322687)
1. APE1/Ref-1 as a Novel Target for Retinal Diseases.
Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
4. The multifunctional APE1 DNA repair-redox signaling protein as a drug target in human disease.
Caston RA; Gampala S; Armstrong L; Messmann RA; Fishel ML; Kelley MR
Drug Discov Today; 2021 Jan; 26(1):218-228. PubMed ID: 33148489
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
[TBL] [Abstract][Full Text] [Related]
6. APE1/Ref-1 - One Target with Multiple Indications: Emerging Aspects and New Directions.
Mijit M; Caston R; Gampala S; Fishel ML; Fehrenbacher J; Kelley MR
J Cell Signal; 2021; 2(3):151-161. PubMed ID: 34557865
[TBL] [Abstract][Full Text] [Related]
7. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.
Shah F; Logsdon D; Messmann RA; Fehrenbacher JC; Fishel ML; Kelley MR
NPJ Precis Oncol; 2017; 1():. PubMed ID: 28825044
[TBL] [Abstract][Full Text] [Related]
8. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.
Kelley MR; Georgiadis MM; Fishel ML
Curr Mol Pharmacol; 2012 Jan; 5(1):36-53. PubMed ID: 22122463
[TBL] [Abstract][Full Text] [Related]
9. Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.
Sardar Pasha SPB; Sishtla K; Sulaiman RS; Park B; Shetty T; Shah F; Fishel ML; Wikel JH; Kelley MR; Corson TW
J Pharmacol Exp Ther; 2018 Oct; 367(1):108-118. PubMed ID: 30076264
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
11. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
12. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.
McIlwain DW; Fishel ML; Boos A; Kelley MR; Jerde TJ
Oncotarget; 2018 Feb; 9(13):10962-10977. PubMed ID: 29541389
[TBL] [Abstract][Full Text] [Related]
13. APE1/Ref-1 Role in Inflammation and Immune Response.
Oliveira TT; Coutinho LG; de Oliveira LOA; Timoteo ARS; Farias GC; Agnez-Lima LF
Front Immunol; 2022; 13():793096. PubMed ID: 35296074
[TBL] [Abstract][Full Text] [Related]
14. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
15. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
16. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.
Schindl M; Oberhuber G; Pichlbauer EG; Obermair A; Birner P; Kelley MR
Int J Oncol; 2001 Oct; 19(4):799-802. PubMed ID: 11562758
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
[TBL] [Abstract][Full Text] [Related]
18. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
20. APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.
Sahakian L; Robinson AM; Sahakian L; Stavely R; Kelley MR; Nurgali K
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
